The ongoing Bundibugyo virus Ebola outbreak, declared a PHEIC by WHO in May 2026, drives market sentiment, with DRC reporting 837 confirmed cases and 196 deaths as of mid-June per CDC and ECDC data, plus 19 confirmed cases in Uganda. This marks the largest known outbreak of this strain, fueled by a likely February spillover, remote locations in Ituri and neighboring provinces, armed conflict, population displacement, and weak surveillance that delays detection and isolation. CDC models project potential growth to thousands of cases without improved containment, while low U.S. risk reflects limited international travel links and screening measures. Key upcoming factors include updated WHO/Africa CDC situation reports, revised transmission models, and any new cross-border detections that could expand the list of affected countries before year-end.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedWhich countries will have an Ebola case in 2026?
Which countries will have an Ebola case in 2026?
$27,464 Vol.
Dec 31, 2026
South Sudan
65%
Rwanda
42%
Burundi
37%
United States
32%
Canada
43%
Kenya
58%
India
30%
Republic of the Congo
19%
Nigeria
24%
Ethiopia
46%
Somalia
24%
China
15%
$27,464 Vol.
South Sudan
$1,159 Vol.
65%
Rwanda
$1,869 Vol.
42%
Burundi
$200 Vol.
37%
United States
$7,683 Vol.
32%
Canada
$982 Vol.
43%
Kenya
$193 Vol.
58%
India
$732 Vol.
30%
Republic of the Congo
$10,221 Vol.
19%
Nigeria
$25 Vol.
24%
Ethiopia
$65 Vol.
46%
Somalia
$71 Vol.
24%
China
$2,308 Vol.
15%
This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.The ongoing Bundibugyo virus Ebola outbreak, declared a PHEIC by WHO in May 2026, drives market sentiment, with DRC reporting 837 confirmed cases and 196 deaths as of mid-June per CDC and ECDC data, plus 19 confirmed cases in Uganda. This marks the largest known outbreak of this strain, fueled by a likely February spillover, remote locations in Ituri and neighboring provinces, armed conflict, population displacement, and weak surveillance that delays detection and isolation. CDC models project potential growth to thousands of cases without improved containment, while low U.S. risk reflects limited international travel links and screening measures. Key upcoming factors include updated WHO/Africa CDC situation reports, revised transmission models, and any new cross-border detections that could expand the list of affected countries before year-end.
This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Market Opened: May 22, 2026, 12:35 PM ET
Volume
$27,464End Date
Dec 31, 2026Market Opened
May 22, 2026, 12:35 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.The ongoing Bundibugyo virus Ebola outbreak, declared a PHEIC by WHO in May 2026, drives market sentiment, with DRC reporting 837 confirmed cases and 196 deaths as of mid-June per CDC and ECDC data, plus 19 confirmed cases in Uganda. This marks the largest known outbreak of this strain, fueled by a likely February spillover, remote locations in Ituri and neighboring provinces, armed conflict, population displacement, and weak surveillance that delays detection and isolation. CDC models project potential growth to thousands of cases without improved containment, while low U.S. risk reflects limited international travel links and screening measures. Key upcoming factors include updated WHO/Africa CDC situation reports, revised transmission models, and any new cross-border detections that could expand the list of affected countries before year-end.
This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Volume
$27,464End Date
Dec 31, 2026Market Opened
May 22, 2026, 12:35 PM ETResolver
0x65070BE91...The ongoing Bundibugyo virus Ebola outbreak, declared a PHEIC by WHO in May 2026, drives market sentiment, with DRC reporting 837 confirmed cases and 196 deaths as of mid-June per CDC and ECDC data, plus 19 confirmed cases in Uganda. This marks the largest known outbreak of this strain, fueled by a likely February spillover, remote locations in Ituri and neighboring provinces, armed conflict, population displacement, and weak surveillance that delays detection and isolation. CDC models project potential growth to thousands of cases without improved containment, while low U.S. risk reflects limited international travel links and screening measures. Key upcoming factors include updated WHO/Africa CDC situation reports, revised transmission models, and any new cross-border detections that could expand the list of affected countries before year-end.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated
Beware of external links.
Beware of external links.
Frequently Asked Questions